EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Mechanisms of diabetic cardiomyopathy: Focus on inflammation

Myriam Bellemare, Liane Bourcier, Josep Iglesies-Grau, Jacinthe Boulet, Eileen O'Meara, Nadia Bouabdallaoui iD

Diabetes, Obesity and Metabolism · 2025-05 · 27 (5) · 2326-2338

DOI: 10.1111/dom.16242 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 10.02.2025. Verfasst von Myriam Bellemare und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Montreal Heart Institute, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Inflammation, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of Review Type 2 diabetes (T2D) significantly increases the risk of heart failure (HF), either through the progression of coronary artery disease (CAD) or through direct myocardial alterations, termed diabetic cardiomyopathy. This review examines key pathophysiological mechanisms underlying diabetic cardiomyopathy, focusing on the role of inflammation. It also addresses diagnostic and therapeutic approaches to mitigate myocardial damage in T2D. Recent Findings Chronic low‐grade inflammation is considered as a major contributor to diabetic cardiomyopathy. T2D‐related factors, including hyperglycemia and insulin resistance, activate inflammatory pathways that worsen myocardial dysfunction. Despite advances in understanding these mechanisms, no therapies specifically targeting the cardiac changes in T2D have been identified. Summary While significant advances have been made in elucidating the inflammatory mechanisms contributing to diabetic cardiomyopathy, therapeutic advancements remain limited, potentially due to an incomplete understanding of regulatory pathways. A comprehensive investigation into the specific roles of immune cells and inflammatory mediators in diabetic cardiomyopathy is essential for identifying novel therapeutic targets. Expanding our knowledge of these molecular mechanisms has the potential to facilitate the development of innovative therapeutic strategies, thereby improving clinical outcomes in patients with T2D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesInflammationDiabetes Mellitus, Type 2HumansInsulin ResistanceAnimals

Stichwörter der Autor:innen

diabetesdiabetic cardiomyopathyfibrosisheart failureinflammation

Autor:innen und Institutionen

  • Department of Medicine, Montreal Heart Institute, Montreal, QC, Canada.
  • Université de Montréal, Montreal, QC, Canada.

ORCID-Profile: Nadia Bouabdallaoui

Zitieren

APA

Bellemare, M., Bourcier, L., Iglesies-Grau, J., Boulet, J., O'Meara, E., & Bouabdallaoui, N. (2025). Mechanisms of diabetic cardiomyopathy: Focus on inflammation. Diabetes, Obesity and Metabolism, 27(5), 2326-2338. https://doi.org/10.1111/dom.16242

Vancouver

Bellemare M, Bourcier L, Iglesies-Grau J, Boulet J, O'Meara E, Bouabdallaoui N. Mechanisms of diabetic cardiomyopathy: Focus on inflammation. Diabetes, Obesity and Metabolism. 2025;27(5):2326-2338. doi:10.1111/dom.16242

BibTeX
@article{Bellemare2025,
  author = {Bellemare, Myriam and Bourcier, Liane and Iglesies-Grau, Josep and Boulet, Jacinthe and O'Meara, Eileen and Bouabdallaoui, Nadia},
  title = {Mechanisms of diabetic cardiomyopathy: Focus on inflammation},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {5},
  pages = {2326--2338},
  doi = {10.1111/dom.16242}
}
Kostenlos starten →